LakeShore Biopharma (LSB) director Shao Hui David discloses direct and indirect share stakes
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
LakeShore Biopharma Co., Ltd. director and President/CBO Shao Hui David filed an initial ownership report showing holdings of Ordinary Shares. He directly owns 133,360 Ordinary Shares and is also deemed to beneficially own 180,278 Ordinary Shares held indirectly through Mountainview Investment Holdings LLC, which he wholly controls as a director.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Shao Hui David
Role
President and CBO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 133,360 shares (Direct);
Ordinary Shares — 180,278 shares (Indirect, See footnote)
Footnotes (1)
- [object Object]
Key Figures
Direct Ordinary Shares owned: 133,360 shares
Indirect Ordinary Shares owned: 180,278 shares
2 metrics
Direct Ordinary Shares owned
133,360 shares
Direct ownership reported by Shao Hui David
Indirect Ordinary Shares owned
180,278 shares
Indirect holdings via Mountainview Investment Holdings LLC
Key Terms
Ordinary Shares, beneficial ownership, indirectly, limited liability company
4 terms
beneficial ownership financial
"therefore may be deemed to have beneficial ownership of the shares held by it"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
indirectly financial
"Represents 180,278 Ordinary Shares held indirectly through Mountainview Investment Holdings LLC"
limited liability company financial
"Mountainview Investment Holdings LLC, a Delaware limited liability company"
A limited liability company (LLC) is a business structure that separates the owners’ personal assets from the company’s debts and legal obligations, like a protective shield that keeps personal savings and property distinct from business risk. For investors, that protection reduces personal financial exposure and often brings flexible rules for profit sharing and taxes, but it can also affect how easily interests are bought or sold and how decisions are made.
FAQ
What does LakeShore Biopharma (LSB) insider Shao Hui David report on this Form 3?
The Form 3 shows that Shao Hui David, a director and President/CBO of LakeShore Biopharma, reports initial ownership of Ordinary Shares, including direct holdings and additional shares held indirectly through an investment LLC he controls, establishing his beneficial ownership position in the company’s equity.
What is Mountainview Investment Holdings LLC’s role in LakeShore Biopharma (LSB) ownership?
Mountainview Investment Holdings LLC holds 180,278 LakeShore Biopharma Ordinary Shares. Shao Hui David serves as a director of, and wholly controls, this Delaware limited liability company, so he may be deemed to beneficially own the shares that the LLC holds on his behalf.
Does this LakeShore Biopharma (LSB) Form 3 show any insider buying or selling?
The Form 3 functions as an initial ownership report and lists Shao Hui David’s direct and indirect Ordinary Share positions. It does not classify any transactions as open-market purchases or sales, focusing instead on disclosing his existing beneficial ownership stakes in the company.
Why is Shao Hui David’s indirect ownership in LakeShore Biopharma (LSB) important?
Indirect ownership via Mountainview Investment Holdings LLC indicates additional economic exposure beyond his direct holdings. Because he wholly controls the LLC, securities rules treat him as having beneficial ownership of those 180,278 shares, providing investors a fuller picture of his total equity interest in LakeShore Biopharma.